Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
Moodys
Colorcon
Express Scripts

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Litigation Details for Allergan USA, Inc. v. Aurobindo Pharma Ltd. (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Allergan USA, Inc. v. Aurobindo Pharma Ltd. (D. Del. 2019)

Docket ⤷  Free Forever Trial Date Filed 2019-09-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ALLERGAN USA, INC.
Patents 10,188,632; 6,251,910; 6,346,532; 6,525,060; 7,250,419; 7,265,124; 8,425,934; 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125
Attorneys Justin E. Culbertson
Firms Morris James LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Allergan USA, Inc. v. Aurobindo Pharma Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .

Details for Allergan USA, Inc. v. Aurobindo Pharma Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-09-13 1 Complaint '587 patent"), 9,789,125 ("the '125 patent"), and/or 10,188,632 ("the…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and External link to document
2021-01-10 140 Opinion - Memorandum Opinion the ʼ489 patent”), 9,789,125 (“the ʼ125 patent”), 9,675,587 (“the ʼ587 patent”), and 10,188,632 (“the ʼ632…terms in U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125, 9,675,587, and 10,188,632.. Signed by…Crystalline Form Patents are the ʼ860 patent, the ʼ091 patent, the ʼ489 patent, and the ʼ125 patent. The Abuse-Deterrent… terms in U.S. Patent Nos. 8,691,860 (“the ’860 patent”), 9,115,091 (“the ʼ091 patent”), 9,364,489 (“…Abuse-Deterrent Patents are the ʼ587 patent and the ʼ632 patent. The parties agreed on the constructions External link to document
2019-09-13 4 Patent/Trademark Report to Commissioner of Patents ,115,091; 9,364,489; 9,675,587; 9,789,125; 10,188,632 (sam) (Entered: 09/16/2019) 13 September 2019… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,691,860; 9,115,091… 13 September 2019 1:19-cv-01727 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-07-15 96 Exhibit A-F and 1-6 . Patent Nos. 6,251 ,910 ; 6,525 ,060; 7,250,419 ; 7,265 ,124; 8,425 ,934; and any other patents or … relates to the subject matter of U.S . Patent Nos. 6,251 ,910; 6,525 ,060; 7,250,419 ; 7,265 ,124; …that its patent portfolio with the asserted patents is "mature," and that the only patent it is…the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board, or any foreign patent office,…be used for any research, development, patent prosecution, patent claim amendments, commercial, marketing External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
Harvard Business School
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.